In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers
Article in Expert Review of Vaccines (April 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination.
Article in Cancer Epidemiology Biomarkers & Prevention (March 2022)
Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
Article in Scientific Reports (February 2021)